TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. ("HEALWELL" or the "Company") (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to announce the Company will release its Fiscal First Quarter 2024 financial results for the period ended March 31, 2024, on Tuesday, May 14, 2024. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 5:00 pm EDT (2:00 pm PDT). The call will be hosted by Dr. Alexander Dobranowski, Chief Executive Officer, and Scott Nirenberski, Chief Financial Officer. Please dial in 10 minutes prior to the start of the call.
Fiscal First Quarter 2024 Conference Call
Date: Tuesday, May 14, 2024
Time: 5:00 PM ET / 2:00 PM PT
For attendees who wish to join by webcast, the event can be accessed at: https://edge.media-server.com/mmc/p/iboe8jex
Attendees who wish to join by phone must visit the following link and pre-register: https://register.vevent.com/register/BI10befc2e470d4f5c82cbd87e488dee0f
Instructions for joining by phone:
Dr. Alexander Dobranowski
Chief Executive Officer
HEALWELL AI
About HEALWELL
HEALWELL is a healthcare technology company focused on AI and data science for preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange (the “TSX”) under the symbol “AIDX” and on the OTC Exchange under the symbol “HWAIF”. To learn more about HEALWELL, please visit https://healwell.ai/.
For more information:
Pardeep Sangha
Investor Relations, HEALWELL AI Inc.
Phone: 604-572-6392
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | C$2.10 |
Daily Change: | -0.09 -4.11 |
Daily Volume: | 1,938,211 |
Market Cap: | C$348.350M |
December 03, 2024 November 12, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB